InvestorsHub Logo

drugmanrx

05/14/19 9:47 AM

#8560 RE: learningcurve2020 #8559

So what's 5 billion shares.

You knew all along that there would be 100 to 1000 to 1 RS split before they had a product to market.

The only question is what will the market cap be if indeed they do have a vaccine for prostate and or ovarian cancer.

10 million, 100 million, 1 billion, 5 billion, 10-20-30 billion?

IMHO, I would expect it to be in the later range.

If so then today stock will be over a dollar even with dilution.

Just for men over 70 on medicare

Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.

https://www.ncbi.nlm.nih.gov/pubmed/30242397

"The estimated total 3-year cost to the Medicare program associated with the annual detection of prostate cancer in men 70 years or older is approximately $1.2 billion. Increasing active surveillance use in those with Gleason score of 6 or lower could reduce this cost by $320 million."


Cost of Care for the Initial Management of Ovarian Cancer

https://journals.lww.com/greenjournal/FullText/2017/12000/Cost_of_Care_for_the_Initial_Management_of_Ovarian.12.aspx

"The average cost of care for women with ovarian cancer in the first year after surgery is approximately $100,000. Patients bear approximately 3% of these costs in the form of out-of-pocket expenses."

"About 21,000 U.S. people get diagnosed with ovarian cancer every year, and about 14,000 die from it. An individual's lifetime risk of developing ovarian cancer is about 1 in 78"

drugmanrx

05/14/19 10:30 AM

#8561 RE: learningcurve2020 #8559

The potential market world wide for an ovarian cancer vaccine.

In people not dollars.

15-24 years: female 572,229,547)
25-54 years: female 1,488,011,505)
55-64 years: female 322,668,546)
65 years and over: female 352,206,092)

The potential market of high risk males worldwide for a prostate vaccine.

55-64 years: male 307,262,939
65 years and older male 283,540,918

BooDog

05/15/19 8:44 AM

#8568 RE: learningcurve2020 #8559

I thought I was making it clear. 5 B authorized means squat if they have transparency and keep shareholders up to date. I'm in another bio that has 10 BILLION authorized and about 242M out, BUT insiders also provide the funding (The funds sourced from lines of credit provided by the Chairman of the Board and a relative of the Chairman of the Board.).

So there are ways for OBMP to improve 10 fold. We just need to see it.

a. increasethe Company’s authorized common stock, par value $0.0001 per share (the “Common Stock”) from 1,500,000,000shares to 5,000,000,000 shares.

I've seen this sheet music before. However, if they prove the science and START BEING TRANSPARENT keeping the updates rolling, conference callS and maybe even surprises (good of course) then the massive dilution will be sucked right up by retail and we could actually see this in the mid .20's+.

Crickets? Nada, see ya at .0001.